Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis

Radiology

Volumn 224, Issue 3, 2002, Pages 748-756

  Kinkel, Karen ^a   Lu, Ying ^a   Both, Marcus ^a   Warren, Robert S ^a   Thoeni, Ruedi F ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Computed tomography (CT), comparative studies; Gastrointestinal tract, neoplasms; Liver neoplasms, metastases; Magnetic resonance (MR), comparative studies; Positron emission tomography (PET), comparative studies; Ultrasound (US), comparative studies

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; COVARIANCE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM CANCER; ECHOGRAPHY; ESOPHAGUS CANCER; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; MEDLINE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; ROC CURVE; SENSITIVITY AND SPECIFICITY; STOMACH CANCER;

EID: 0036721291     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2243011362     Document Type: Article

References (61)

1. Liver resection for colorectal metastases
2. Sequential hepatic and pulmonary resections for metastatic colorectal cancer
3. Resection of liver metastases of colorectal carcinoma
4. Intrahepatic arterial infusion chemotherapy for the colon cancer patients with liver metastases: A comparison of arterial embolization chemotherapy versus continuous arterial infusion chemotherapy
5. Detection of hepatic metastases in colorectal cancer: A prospective study of laboratory and imaging methods
6. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer
7. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer
8. Detection of colorectal liver metastases: Comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results
9. A prospective study of six methods for detection of hepatic colorectal metastases
10. CT and MR imaging in the staging of colorectal carcinoma: Report of the Radiology Diagnostic Oncology Group II
11. Diagnosis of liver metastases from colorectal adenocarcinoma: Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging
12. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings
13. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum
14. Guidelines for meta-analyses evaluating diagnostic tests
15. Generalized linear models
16. Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis
17. Use of meta-analysis in the evaluation of imaging systems
18. Meta-analytic methods for diagnostic test accuracy
19. Analysis of longitudinal data
20. The value of hepatic ultrasound and biochemical liver tests in screening for liver metastases
21. Role of ultrasound in the diagnosis of liver metastases before surgery for large bowel cancer
22. Laparoscopy, ultrasound and computed tomography in cancer of the oesophagus and gastric cardia: A prospective comparison for detecting intra-abdominal metastases
23. Preoperative assessment of resectability of hepatic metastases from co-Ionic carcinoma: CT portography vs sonography and dynamic CT
24. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer
25. Colorectal carcinoma evaluation with CT: Preoperative staging and detection of postoperative recurrence
26. Carcinoma of the colon: Detection and preoperative staging by CT
27. Computed tomographic diagnosis of rectal tumors
28. How useful is pre-operative computerized tomography scanning in staging rectal cancer?
29. Preoperative CT staging of colon carcinoma (excluding the recto-sigmoid region)
30. Predictive value of a negative computed tomographic scan in 100 patients with rectal carcinoma
31. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer: Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response
32. Role of computed tomographic scans in the staging of esophageal and proximal gastric malignancies
33. Preoperative assessment of advanced gastric carcinoma using computed tomography
34. Spiral computed tomography and operative staging of gastric carcinoma: A comparison with histopathological staging
35. Staging recurrent metastatic colorectal carcinoma with PET
36. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma
37. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis
38. MRI of liver metastases from colorectal cancer vs. CT during arterial portography
39. Hepatic malignancies: Usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging
40. Ferumoxide-enhanced MRI in patients with colorectal cancer and rising CEA: Surgical correlation in early recurrence
41. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver
42. Impact of 18F-FDG-positron emission tomography for decision making in colorectal cancer recurrences
43. Value of positron emission tomography (18F-FDG-PET) in the diagnosis of recurrent rectal cancer
44. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer
45. Diagnosing liver metastases: A Bayesian analysis
46. Metastases: Mechanisms, pathways, and cascades
47. Hepatic metastases in gastrointestinal cancer: Diagnostic value of biochemical investigations
48. Prognosis of carcinoma of the large bowel in the presence of liver metastases
49. Decision analysis for the cost-effective management of recurrent colorectal cancer
50. FDG-PET in the detection of recurrence in colorectal cancer based on rising CEA Level: Experience in 72 patients
51. Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making?
52. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: The utility of positron emission tomography (PET)
53. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: A prospective database study
54. A study of prognostic factors for hepatic resection for colorectal metastases
55. Colorectal cancer: Radiologic staging
56. The diagnostic accuracy/efficacy of MRI in differentiating hepatic hemangiomas from metastatic colorectal/breast carcinoma: A multiple reader ROC analysis using a jackknife technique
57. Focal liver lesions: MR imaging with Mn-DPDP-initial clinical results in 40 patients
58. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests
59. Preoperative detection of malignant hepatic tumors: Comparison of combined methods of MR imaging with combined methods of CT